What is the VRAX stock price prediction for next 2 weeks?

According to our price prediction algorithm,Virax Biolabs Group Limited (VRAX) price will be around $3.01 in the next 2 weeks. This means it will decrease by -25.995085995085997 from the last closing price. This prediction may vary from other time period filters for VRAX stock.

What can be the highest Possible price of VRAX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, VRAX can achieve the highest price of $4.01 which is -1.5036629379409023 lower than last closing price. This prediction may vary from other time period filters for VRAX stock.

What can be the lowest Possible price of VRAX stock in next 2 weeks?

As per the forecast and algorithmic analysis, VRAX stock price can be as low as $1.98 which is -51.46770886964009 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for VRAX stock.

Will VRAX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that VRAX stock will lose-25.995085995085997 in the next 2 weeks. This prediction may vary from other time period filters for VRAX stock.

What is VRAX stock last closing price?

Last closing price of VRAX stock was $4.07.

What is VRAX stock price prediction?

VRAX stock price prediction means predicting the future closing prices of VRAX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of VRAX stock in a certain time period.

How we predict VRAX stock future prices?

If you are searching for VRAX stock forecast, analysis or price prediction, then you might be wondering what Virax Biolabs Group Limited (VRAX) will do in the future. Our VRAX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This VRAX price prediction will likely answer most of your questions.

How frequent we update VRAX stock predictions?

We are updating the forecasts for the VRAX stock on daily basis.

Is using ML forecasting for VRAX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for VRAX stock same for all the time periods?

No, the prediction for VRAX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Virax Biolabs Group Limited Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$4.0724.85%Since 2 Weeks

Predicted Price$3.01-26%For 2 Weeks

Upper Predicted Price$4.01-1.5%For 2 Weeks

Lower Predicted Price$1.98-51.47%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of VRAX will decline by -26.00% over the next 2 Weeks and hit $3.01 by Monday, July 27, 2026. In that time frame, VRAX's share price is expected to range between $1.98 and $4.01.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jul 27, 2026	1.98	3.01	4.01
Jul 24, 2026	2.23	3.21	4.16
Jul 23, 2026	2.88	3.88	4.91
Jul 22, 2026	2.58	3.59	4.55
Jul 21, 2026	2.36	3.35	4.34
Jul 20, 2026	2.60	3.49	4.48
Jul 17, 2026	2.74	3.69	4.69
Jul 16, 2026	3.33	4.36	5.27
Jul 15, 2026	3.10	4.07	5.07
Jul 14, 2026	2.87	3.83	4.81

VRAX shares fell -0.25% in Monday, July 13, 2026's trading session, dropping from a previous close of $4.08 to move at $4.07. The stock demonstrated notable intraday movement (see VRAX's key stats for a full breakdown), fluctuating between $3.79 and $4.59, a +21.11% trading range. While recent weeks have seen some volatility, VRAX has managed to secure a +24.85% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 982.86K shares changing hands, 734.82K fewer than the previous session. This amounted to $4.00M in total market activity.

Will VRAX Continue Its Downward Trend?

According to analyst ratings and projections for VRAX, Virax Biolabs Group Limited shares are anticipated to decrease by -1.53%, potentially reaching $4.01 per share by July 27, 2026. Short-term technical indicators for VRAX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the VRAX stock forecast, now is not the best time to buy VRAX stock because its current trading price is +35.13% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on VRAX covering social and institutional perspectives.

VRAX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into VRAX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.63% to 51.55%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.51%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.39%, maintains a neutral outlook for the long term. Insights into VRAX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Virax Biolabs Group Short-Term Forecasts

VRAX Forecast For Next 5 Days

Our algorithm anticipates Virax Biolabs Group (VRAX) stock could hit $6.49 by Jul 20, 2026. This represents a +59.43% fall from today's price, following a -16.37% change over the past five days.

VRAX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Virax Biolabs Group Limited (VRAX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.03, which would mean a -0.98% decrease from the current price of $4.07. Projections for this period range from a high of $7.72 to a low of $1.37.

VRAX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Virax Biolabs Group's price over the next three months point to a drop. VRAX stock is expected to peak at $8.55 on Sep 01, 2026 before potentially dipping to $0.00 on Oct 13, 2026. On average, VRAX is likely to trade around $3.82 in the coming 90 days.

Virax Biolabs Group Stock Forecast 2025

Based on our predictive models, Virax Biolabs Group (VRAX) is expected to trade between $0.00 and $8.55 throughout 2026. This would result in an average price of $3.06, potentially offering investors a -24.82% return from current levels.

Virax Biolabs Group Limited Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Virax Biolabs Group Limited (VRAX) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.36 and $7.08, settling at an average of $3.54. This could translate to a -13.02% loss.

August 2026

Based on current market signals, Virax Biolabs Group Limited is projected to trend august 2026. We forecast a trading range from $0.16 to $7.89, with a likely average price of $3.92. Investors could expect a potential return of -3.69%.

September 2026

Our predictive algorithms indicate Virax Biolabs Group Limited stock may see a shift in September 2026. The expected range spans $0.40–$8.55, with an average target of $4.33. This represents a positive outlook and a possible gain of +6.39%.

October 2026

Analyzing established trends, Virax Biolabs Group Limited looks set to move in October 2026. Projections place the stock between $0.00 and $6.25, averaging around $2.39. This suggests a -41.28% loss from current levels.

November 2026

Market indicators suggest Virax Biolabs Group Limited could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $6.20, with a midpoint forecast of $2.71. The stock might deliver a -33.42% loss.

December 2026

Forecasting for December 2026, models estimate that Virax Biolabs Group Limited may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $5.03, averaging $1.76. This signals a cautious trajectory with potential returns around -56.76%.

January 2027

According to our latest forecast models, Virax Biolabs Group Limited (VRAX) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $4.89, settling at an average of $1.62. This could translate to a -60.20% loss.

February 2027

Based on current market signals, Virax Biolabs Group Limited is projected to trend february 2027. We forecast a trading range from $0.00 to $4.78, with a likely average price of $1.65. Investors could expect a potential return of -59.46%.

March 2027

Our predictive algorithms indicate Virax Biolabs Group Limited stock may see a shift in March 2027. The expected range spans $0.00–$4.56, with an average target of $0.96. This represents a cautious outlook and a possible loss of -76.41%.

April 2027

Analyzing established trends, Virax Biolabs Group Limited looks set to move in April 2027. Projections place the stock between $0.00 and $4.42, averaging around $0.96. This suggests a -76.41% loss from current levels.

May 2027

Market indicators suggest Virax Biolabs Group Limited could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $3.53, with a midpoint forecast of $0.53. The stock might deliver a -86.98% loss.

June 2027

Forecasting for June 2027, models estimate that Virax Biolabs Group Limited may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.26, averaging $0.58. This signals a cautious trajectory with potential returns around -85.75%.

July 2027

According to our latest forecast models, Virax Biolabs Group Limited (VRAX) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $2.92, settling at an average of $0.67. This could translate to a -83.54% loss.

VRAX's history of dividends and stock splits also plays a role in long-term investor confidence.